Evogene Ltd. (TLV:EVGN)

Evogene Revenue

Evogene had revenue of $334.00K USD in the quarter ending March 31, 2026, a decrease of -85.74%. This brings the company's revenue in the last twelve months to $1.84M, down -70.41% year-over-year. In the year 2025, Evogene had annual revenue of $3.85M, down -30.91%.

• Revenue (ttm): $1.84M
• Revenue Growth: -70.41%
• P/S Ratio: 2.93
• Revenue / Employee: $35.46K
• Employees: 52
• Market Cap: 17.07M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.85M	-1.72M	-30.91%
Dec 31, 2024	5.58M	2.60M	87.02%
Dec 31, 2023	2.98M	1.31M	78.03%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	753.00K	-994.00K	-56.90%
Dec 31, 2018	1.75M	-1.63M	-48.33%
Dec 31, 2017	3.38M	-3.16M	-48.30%
Dec 31, 2016	6.54M	-4.59M	-41.23%
Dec 31, 2015	11.13M	-3.38M	-23.31%
Dec 31, 2014	14.51M	-3.07M	-17.46%
Dec 31, 2013	17.58M	509.00K	2.98%
Dec 31, 2012	17.07M	2.17M	14.57%
Dec 31, 2011	14.90M	2.34M	18.61%
Dec 31, 2010	12.56M	-	-

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error